THE ROLE OF IMMUNOTHERAPY IN ACUTE MYELOGENOUS LEUKEMIA

被引:44
作者
FOON, KA
SMALLEY, RV
RIGGS, CW
GALE, RP
机构
[1] NCI,FREDERICK CANC RES FACIL,BIOL THERAPEUT BRANCH,FREDERICK,MD 21701
[2] NCI,FREDERICK CANC RES FACIL,BIOL RESOURCES BRANCH,FREDERICK,MD 21701
[3] NCI,FREDERICK CANC RES FACIL,DIV CANC TREATMENT,FREDERICK,MD 21701
[4] NCI,FREDERICK CANC RES FACIL,COMP & STAT SERV GRP,FREDERICK,MD 21701
[5] UNIV CALIF LOS ANGELES,CTR HLTH SCI,SCH MED,DEPT MED,DIV HEMATOL,LOS ANGELES,CA 90024
[6] UNIV CALIF LOS ANGELES,CTR HLTH SCI,SCH MED,DEPT MED,DIV ONCOL,LOS ANGELES,CA 90024
[7] UNIV CALIF LOS ANGELES,CTR HLTH SCI,SCH MED,DEPT MICROBIOL,LOS ANGELES,CA 90024
[8] UNIV CALIF LOS ANGELES,CTR HLTH SCI,SCH MED,DEPT IMMUNOL,LOS ANGELES,CA 90024
[9] UNIV CALIF LOS ANGELES,CTR HLTH SCI,SCH MED,TRANSPLANTAT BIOL UNIT,LOS ANGELES,CA 90024
关键词
D O I
10.1001/archinte.143.9.1726
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1726 / 1731
页数:6
相关论文
共 37 条
[1]  
ANDRIEN JM, 1978, IMMUNOTHERAPY CANCER, P471
[2]   IMPROVED REMISSION INDUCTION-RATE WITH D-ZAPO BUT UNIMPROVED REMISSION DURATION WITH ADDITION OF IMMUNOTHERAPY TO CHEMOTHERAPY IN PREVIOUSLY UNTREATED CHILDREN WITH ANLL [J].
BAEHNER, RL ;
BERNSTEIN, ID ;
SATHER, H ;
HIGGINS, G ;
MCCREADIE, S ;
CHARD, RL ;
HAMMOND, D .
MEDICAL AND PEDIATRIC ONCOLOGY, 1979, 7 (02) :127-139
[3]  
BAKER MA, 1982, CANCER IMMUNOL IMMUN, V13, P85
[4]  
BEKASI JG, 1982, P AM SOC CLIN ONCOL, V1, P36
[5]  
CUTTNER J, 1982, IMMUNOTHERAPY HUMAN, P33
[6]  
EPPINGERHELFT M, 1980, CANCER, V45, P280, DOI 10.1002/1097-0142(19800115)45:2<280::AID-CNCR2820450213>3.0.CO
[7]  
2-O
[8]   CONTROVERSIES IN THE THERAPY OF ACUTE MYELOGENOUS LEUKEMIA [J].
FOON, KA ;
GALE, RP .
AMERICAN JOURNAL OF MEDICINE, 1982, 72 (06) :963-979
[9]   INTENSIVE CHEMOTHERAPY FOR ACUTE MYELOGENOUS LEUKEMIA [J].
GALE, RP ;
FOON, KA ;
CLINE, MJ ;
ZIGHELBOIM, J .
ANNALS OF INTERNAL MEDICINE, 1981, 94 (06) :753-757
[10]  
GUTTERMA.JU, 1974, LANCET, V2, P1405